SPDR S&P Pharmaceuticals ETF Rating $57.96 +1.65 (+2.93%) As of 01:32 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.62Holdings in XPH have an aggregate rating of Moderate Buy based on 275 analyst ratings issued in the past year covering 25 companies (55.3% of the portfolio).XPH Aggregate Price Target$56.31-2.15% DownsideHigh Prediction$56.31Average Prediction$56.31Low Prediction$56.31Holdings in XPH have an aggregate price target of $56.31 and a range of $56.31 to $56.31 covering 25 companies (55.3% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.83%OGNOrganon & Co.$13.400.0%2.4501 of 5 stars1.71$11.40 -14.9%7Positive News3.26%CORTCorcept Therapeutics$74.58+2.6%4.262 of 5 stars2.75$88.83 19.1%8Analyst ForecastInsider TradeAnalyst Revision2.89%LQDALiquidia$64.19+15.3%2.3972 of 5 stars2.91$50.88 -20.7%11Insider Trade2.70%AXSMAxsome Therapeutics$235.63+0.9%2.331 of 5 stars2.90$251.26 6.6%21News CoverageAnalyst ForecastInsider Trade2.47%ELVNEnliven Therapeutics$36.45+1.2%3.3408 of 5 stars2.83$61.80 69.6%6News CoverageAnalyst Forecast2.36%JAZZJazz Pharmaceuticals$238.93+3.5%2.6098 of 5 stars2.89$242.65 1.6%192.21%DFTXDefinium Therapeutics$24.20+2.6%3.2978 of 5 stars3.00$37.92 56.7%152.18%VTRSViatris$15.83+1.7%3.1252 of 5 stars2.38$16.43 3.8%82.16%TRVITrevi Therapeutics$13.88+3.2%3.6261 of 5 stars3.00$22.90 65.0%12Positive News2.13%RPRXRoyalty Pharma$55.19+0.4%4.4768 of 5 stars3.00$53.71 -2.7%7Positive News2.13%ESPREsperion Therapeutics$3.14-0.2%4.1059 of 5 stars2.00$5.54 76.7%8Short Interest Decrease2.09%INDVIndivior$37.42+5.6%2.2587 of 5 stars3.00$39.33 5.1%72.09%PRGOPerrigo$10.45-0.1%3.7012 of 5 stars2.00$19.33 85.1%61.98%MBXMBX Biosciences$30.74+2.3%3.1867 of 5 stars2.77$60.22 95.9%131.98%ANIPANI Pharmaceuticals$78.21+4.0%3.7688 of 5 stars2.63$107.33 37.2%8Positive NewsAnalyst Forecast1.95%LLYEli Lilly and Company$1,126.33+4.4%4.1728 of 5 stars2.87$1,227.00 8.9%30Trending NewsGap Up1.93%EWTXEdgewise Therapeutics$37.36+3.2%2.2762 of 5 stars2.78$44.22 18.4%9Analyst ForecastAnalyst Revision1.92%MRKMerck & Co., Inc.$118.75+3.5%4.3573 of 5 stars2.68$128.18 7.9%19Positive NewsGap Up1.91%HRMYHarmony Biosciences$32.67+1.8%4.6125 of 5 stars2.27$40.89 25.2%11Positive News1.89%LGNDLigand Pharmaceuticals$235.66+0.5%3.1528 of 5 stars2.88$257.71 9.4%8Positive NewsInsider Trade1.88%NUVBNuvation Bio$5.28+11.8%3.0746 of 5 stars2.55$12.50 137.0%111.87%XERSXeris Biopharma$6.07+3.0%3.4428 of 5 stars2.43$10.80 78.1%7Insider Trade1.87%PCRXPacira BioSciences$22.60+1.3%3.9328 of 5 stars2.29$29.40 30.1%71.83%INVAInnoviva$22.20+2.3%3.3468 of 5 stars2.57$36.20 63.1%7Analyst ForecastAnalyst Revision1.82%CRNXCrinetics Pharmaceuticals$34.39+3.9%3.2237 of 5 stars2.90$76.13 121.4%10 This page (NYSEARCA:XPH) was last updated on 6/4/2026 by MarketBeat.com Staff. From Our PartnersSkip the Line Opportunity: The SpaceX IPOFormer tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredTrump’s secret China dealTrump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, J...Porter & Company | SponsoredJune 4: The day smart money moves (not June 12)Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...Behind the Markets | SponsoredWashington just moved up the "go broke" date on Social SecurityThe Congressional Budget Office just moved up Social Security's trust fund depletion date to 2032 - a full yea...Investors Alley | SponsoredAI breakthrough hidden inside SpaceX exposed on June 11On June 11, SpaceX is hosting a major investor event - and growth investor Louis Navellier believes Elon Musk ...InvestorPlace | SponsoredJon Najarian’s Important SpaceX PREDICTIONMost investors are focused on SpaceX's projected June 12 IPO date - but they may be missing the bigger story h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
